If you are a short you better have clean underwear
Post# of 72440
So how far off can we be? Leo in an interview on 10/30/15 with the Boston Biz Journal said this....
"Today Cellceutix issued an update largely to say that it has smoothed out the manufacturing process for brilacidin in anticipation of the start of a Phase 3 trial by the end of March of next year. In total, the company expects to test the drug in 1,400 patients in two Phase 3 trials (700 patients each), but has not said how long it expects the trials to take."